Ingevity Crecimiento futuro

Future controles de criterios 3/6

Se prevé que los ingresos de Ingevity disminuyan a un ritmo anual de 0.08%, mientras que se prevé que sus beneficios anuales crezcan a un ritmo de 88.1% por año. Se espera que el BPA crezca en un 87.2% al año.

Información clave

88.1%

Tasa de crecimiento de los beneficios

87.2%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals	15.1%
Tasa de crecimiento de los ingresos	-0.08%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Good
Última actualización	22 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts

Nov 10

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Oct 07

Ingevity Corporation: The Risk To Reward Is Currently Favorable

Oct 06

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Sep 22

Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 31% Undervaluation?

Aug 11

Ingevity Corporation: Headwinds Are Temporary

Jul 05

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Jun 21

Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?

May 29

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Feb 16

Is Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?

Jan 25

Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate

Sep 13

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Aug 22

Ingevity to acquire pavement marking materials business Ozark Materials for $325M

Aug 02

Ingevity (NYSE:NGVT) Seems To Use Debt Quite Sensibly

Aug 01

Ingevity (NYSE:NGVT) Will Want To Turn Around Its Return Trends

Jun 05

What Does Ingevity Corporation's (NYSE:NGVT) Share Price Indicate?

May 20

Ingevity: Well-Diversified ESG Chemicals Company To Put On Watchlist

May 03

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

May 02

Investors Could Be Concerned With Ingevity's (NYSE:NGVT) Returns On Capital

Mar 03

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Jan 19

Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 42%?

Dec 06

Be Wary Of Ingevity (NYSE:NGVT) And Its Returns On Capital

Nov 18

Is Ingevity (NYSE:NGVT) A Risky Investment?

Oct 04

An Intrinsic Calculation For Ingevity Corporation (NYSE:NGVT) Suggests It's 38% Undervalued

Sep 04

Investors Met With Slowing Returns on Capital At Ingevity (NYSE:NGVT)

Aug 20

If You Like EPS Growth Then Check Out Ingevity (NYSE:NGVT) Before It's Too Late

Aug 05

Ingevity (NYSE:NGVT) Has A Pretty Healthy Balance Sheet

Jun 28

Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 25% Undervaluation?

May 22

Investors Could Be Concerned With Ingevity's (NYSE:NGVT) Returns On Capital

May 04

Ingevity Corporation 2021 Q1 - Results - Earnings Call Presentation

Apr 30

Previsiones de crecimiento de beneficios e ingresos

NYSE:NGVT - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	1,591	N/A	194	324	2
12/31/2025	1,544	185	185	308	7
12/31/2024	1,456	133	93	200	7
12/31/2023	1,692	-5	95	205	N/A
9/30/2023	1,704	127	129	259	N/A
6/30/2023	1,740	177	120	252	N/A
3/31/2023	1,678	202	154	294	N/A
12/31/2022	1,668	212	171	313	N/A
9/30/2022	1,621	225	160	291	N/A
6/30/2022	1,516	146	171	291	N/A
3/31/2022	1,454	130	152	266	N/A
12/31/2021	1,392	118	190	293	N/A
9/30/2021	1,381	135	273	370	N/A
6/30/2021	1,336	209	272	360	N/A
3/31/2021	1,248	185	264	343	N/A
12/31/2020	1,216	181	270	352	N/A
9/30/2020	1,194	180	199	285	N/A
6/30/2020	1,222	170	222	313	N/A
3/31/2020	1,304	206	238	344	N/A
12/31/2019	1,293	184	161	276	N/A
9/30/2019	1,268	182	159	276	N/A
6/30/2019	1,219	171	131	252	N/A
3/31/2019	1,175	161	126	234	N/A
12/31/2018	1,134	169	158	252	N/A
9/30/2018	1,085	169	134	207	N/A
6/30/2018	1,037	153	132	193	N/A
3/31/2018	989	138	122	178	N/A
12/31/2017	972	127	122	174	N/A
9/30/2017	954	94	N/A	187	N/A
6/30/2017	942	53	N/A	144	N/A
3/31/2017	927	45	N/A	131	N/A
12/31/2016	908	35	N/A	128	N/A
9/30/2016	898	34	N/A	111	N/A
6/30/2016	902	64	N/A	100	N/A
3/31/2016	919	66	N/A	92	N/A
12/31/2015	958	80	N/A	72	N/A
9/30/2015	999	99	N/A	76	N/A
6/30/2015	1,025	115	N/A	111	N/A
3/31/2015	1,022	121	N/A	106	N/A
12/31/2014	1,036	129	N/A	139	N/A
12/31/2013	980	119	N/A	137	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que NGVT sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que NGVT sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que NGVT sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos de NGVT disminuyan en los próximos 3 años (-0.08% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos de NGVT disminuyan en los próximos 3 años (-0.08% al año).

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de NGVT se prevé que sea elevada dentro de 3 años.

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Ingevity Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Ingevity Corporation Provides Earnings Guidance for the Year 2024

Price target decreased by 8.9% to US$53.29

Consensus EPS estimates fall by 13%

Price target decreased by 11% to US$58.50

Consensus EPS estimates fall by 29%

Price target decreased by 8.9% to US$69.14

Recent updates

Ingevity Corporation to Report Q1, 2024 Results on May 01, 2024

Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?

Is Ingevity (NYSE:NGVT) A Risky Investment?

Ingevity Corporation Announces Resignation of William J. Slocum from Board

Ingevity Corporation, Annual General Meeting, Apr 23, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Ingevity Corporation Provides Earnings Guidance for the Year 2024

Ingevity Corporation to Report Q4, 2023 Results on Feb 21, 2024

What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?

Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares

These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts

Price target decreased by 8.9% to US$53.29

Consensus EPS estimates fall by 13%

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 11% to US$58.50

Ingevity Corporation to Report Q3, 2023 Results on Nov 01, 2023

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Ingevity Corporation: The Risk To Reward Is Currently Favorable

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 31% Undervaluation?

Consensus EPS estimates fall by 29%

Now 20% undervalued after recent price drop

Price target decreased by 8.9% to US$69.14

New major risk - Financial position

Second quarter 2023 earnings: EPS misses analyst expectations

Ingevity Corporation to Report Q2, 2023 Results on Aug 02, 2023

Ingevity Corporation: Headwinds Are Temporary

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Investor sentiment improves as stock rises 16%

Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?

Consensus EPS estimates fall by 13%

Investor sentiment deteriorates as stock falls 20%

Price target decreased by 8.5% to US$88.71

Ingevity Corporation Announces Sales Guidance for 2023

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Insider recently sold US$117k worth of stock

Consensus EPS estimates fall by 11%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

Ingevity Corporation to Report Q4, 2022 Results on Feb 27, 2023

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Is Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?

Insider recently sold US$67k worth of stock

Insider exercised options and sold US$54k worth of stock

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Ingevity Corporation Provides Earnings Guidance for the Year 2022

Ingevity Corporation to Report Q3, 2022 Results on Nov 02, 2022

Ingevity Corporation (NYSE:NGVT) acquired Ozark Logistics, LLC and Ozark Materials, LLC from Ozark Holdings, Inc. for approximately $330 million.

Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Ingevity Corporation (NYSE:NGVT) reached an agreement to acquire Ozark Logistics, LLC and Ozark Materials, LLC from Ozark Holdings, Inc. for approximately $330 million.

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Ingevity Corporation Re-Affirms Earnings Guidance for the Year 2022

Ingevity to acquire pavement marking materials business Ozark Materials for $325M

Ingevity (NYSE:NGVT) Seems To Use Debt Quite Sensibly

Ingevity Corporation Announces Changes to Its Board of Directors

Ingevity Corporation to Report Q2, 2022 Results on Aug 02, 2022

Ingevity Appoints Christine Stunyo as Chief Human Resources Officer

Ingevity (NYSE:NGVT) Will Want To Turn Around Its Return Trends

What Does Ingevity Corporation's (NYSE:NGVT) Share Price Indicate?

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Ingevity Corporation Raises Earnings Guidance for the Year 2022

Ingevity: Well-Diversified ESG Chemicals Company To Put On Watchlist

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Insufficient new directors

Ingevity Corporation to Report Q1, 2022 Results on May 04, 2022

Insufficient new directors

Investor sentiment deteriorated over the past week

Investors Could Be Concerned With Ingevity's (NYSE:NGVT) Returns On Capital

Insufficient new directors